Enable Injections, Inc.
Enable Injections develops and manufactures on-body delivery systems designed to improve the patient experience. For more information, please visit www.enableinjections.com.
*Currently for investigational use only
Enable Injections develops and manufactures on-body delivery systems designed to improve the patient experience. For more information, please visit www.enableinjections.com.
*Currently for investigational use only
Location: United States
Employees: 51-200
Phone: +1 513-326-2800
Total raised: $275M
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | Ohio Innov... | ohioinnova... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 08.01.2026 | - | $30M | - |
| 21.02.2022 | Series C | $215M | - |
| 05.10.2016 | Series A | $30M | - |
Mentions in press and media 23
| Date | Title | Description |
| 23.03.2026 | Philips Proposes New Appointment and Re-Appointments to Its Supervisory Board and CEO Re-Appointment | , a global leader in health technology, announced a proposed Supervisory Board appointment and re-appointments, in addition to the previously announced proposal to re-appointment its President/CEO. The Supervisory Board will submit to the A... |
| 11.01.2026 | Enable Injections Secures $30M Sanofi Investment for On-Body Delivery System Expansion | Enable Injections receives a $30 million investment from Sanofi. This capital targets a major manufacturing expansion for its enFuse On-Body Delivery System. The wearable technology delivers large-volume subcutaneous medicines. Funds also b... |
| 08.01.2026 | Enable Injections Announces $30 Million Sanofi Investment To Expand enFuse On-Body Injector Manufacturing | Enable Injections announced that Sanofi is making a $30 million investment in the Cincinnati-based drug delivery company to accelerate a manufacturing build-out, bolster supply chain capabilities, and support commercial growth for its enFus... |
| 07.01.2026 | Enable Injections Receives $30M Investment from Sanofi | Enable Injections, a Cincinnati, OH-based healthcare company developing and manufacturing the enFuse On-Body Delivery System (OBDS), received $30M investment from Sanofi. It closed a $215M Series C financing in January 2022 led by Magnetar ... |
| 12.09.2024 | Sobi® and Enable Injections announce agreement to develop and distribute Aspaveli® in combination with enFuse® in Sobi territories | Sobi® and Enable Injections announce agreement to develop and distribute Aspaveli® in combination with enFuse® in Sobi territories Thu, Sep 12, 2024 14:00 CET Report this content Sobi® (STO: SOBI) and Enable Injections, Inc. (Enable) today ... |
| 15.03.2022 | Sanofi announces €300 million collaboration with Blackstone Life Sciences to advance an innovative treatment for multiple myeloma | Sanofi announces €300 million collaboration with Blackstone Life Sciences to advance an innovative treatment for multiple myeloma Investment will accelerate the overall Sarclisa® development program Sanofi will continue to fully manage the ... |
| 29.01.2022 | Enable Injections Raises $215M in Funding | Enable Injections, Inc., a Cincinnati, OH-based company developing and manufacturing the enFuse platform of investigational wearable drug delivery systems, raised $215m in Series C financing. The round was led by Magnetar Capital with parti... |
| 29.01.2022 | Enable Injections Announces $215M Series C | CINCINNATI, OH, Enable Injections, a company developing wearable drug delivery systems, has announced $215M in Series C financing led by Magnetar Capital. >> Click here for more funding data on Enable Injections >> To export... |
| 27.01.2022 | Enable Injections shatters region's previous fundraising record with $215M Series C | - |
| 27.01.2022 | Enable Injections Announces $215 Million Financing | New financing provides significant financial flexibility to propel growth efforts, benefitting patients, providers, and pharma partners worldwide. CINCINNATI, Jan. 27, 2022 /PRNewswire/ -- Enable Injections, Inc. ("Enable"), a com... |
Show more